13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-10-15 Event — SEC 0000904454-26-000517 →

Johnson & Johnson Innovation - JJDC, Inc. → TRex Bio, Inc. TRXB

Stake: — Shares: — Class: Common Stock, $0.0001 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
6 transactions
6 buys · 0 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest
—
Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-10-08 MARCUS JOEL S director Award 17,500 $14.00 $245K
2026-10-08 Coy Travis Alan director Award 17,500 $14.00 $245K
2026-10-08 Ross Michael Jay director Award 17,500 $14.00 $245K
2026-10-08 Hirth Peter director Award 17,500 $14.00 $245K
2026-10-08 Gallagher Carol Giltner director Award 17,500 $14.00 $245K
2026-10-08 Gilmore Julie Ann director Award 17,500 $14.00 $245K

Other 13D/G Filings on TRex Bio, Inc.

FiledFormFilerStakeShares
2026-10-16 SCHEDULE 13D ELI LILLY & Co 19.90% 5,480,872 view →
2026-10-16 SCHEDULE 13D SV Biotech Crossover Opportunities Fund LP 7.00% 1,920,667 view →
2026-10-16 SCHEDULE 13G PFIZER INC — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →